R e s e a r c h
M a r k e t
P e r s i s t e n c e
Report Media Releases
Intracranial Stents Market Increasing By Growing Demography &
Economy, 2021
The intracranial devices market is growing at a significant rate due to the increasing prevalence of intracranial disorders,
which may be caused due to various factors such as genetic disorders and accidents. Intracranial devices can be
classified into various categories such as craniomaxillofacial implants, intracranial stents, and others. Endovascular
treatment is widely used for the treatment of cerebral aneurysms (ruptured or unruptured). An intracranial stent refers
to a tubular structure that is placed inside the canal, duct, or blood vessel. It is used to provide relief from obstruction.
It allows continuous flow of the fluid. On the basis of design, intracranial stents can be segmented into open-cell and
closed-cell. On the basis of type, intracranial stents may be classified into Neuroform, Solitaire, Enterprise, Leo Plus,
and Wingspan. Physical features, dimensions, and functional characteristics vary between different types of intracranial
stents. Wingspan is widely used for the treatment of intracranial atherosclerotic diseases; whereas, Neuroform, Solitaire,
Enterprise, and Leo Plus assist in coiling. Intracranial stents market is growing at a significant rate due to the increasing
prevalence of intracranial disorders, which are caused by the blockage of vessels. In addition, government initiatives
and growing awareness in the field are driving the market for intracranial stents. However, factors such as high treatment
costs and lack of skilled professionals for performing the surgery, restrain the growth of the market.
Request to view TOC : http://www.persistencemarketresearch.com/toc/4486
North America dominates the global market for intracranial stents due to the presence of a large aging population and
increased adoption of cranio maxillofacial implants in the region. In addition, technological advancements in the field
are driving the market for intracranial stents in North America. Asia, followed by Europe, is expected to grow at a high
rate in the next few years in the intracranial stents market. China and India are expected to be the fastest growing
intracranial stents markets in Asia. Some of the key driving forces for the intracranial stents market in emerging countries
are the presence of a large pool of patients and rising government initiatives in the form of funding and strict laws. In
addition, increasing awareness about the availability of different types of implants is also driving the market for
intracranial stents.
One of the major factors that have been driving the global intracranial stents market is increase in the prevalence of
intracranial disorders and disruptions. In addition, factors such as rising awareness, technological advancements,
government initiatives, and improvement in the reimbursement scenario in the field are driving the global intracranial
stents market. However, factors such as the high treatment costs and lack of experienced professionals are restraining
the growth of the global intracranial stents market. In addition, the lesser adoption rate of intracranial stents is further
restraining the market.
Growing demographics and economies in developing countries such as India and China are expected to offer good
opportunities for the global intracranial stents market. Introduction of some new products with better efficiency is also
expected to create good opportunities for the global intracranial stents market. Rising n umber of mergers and
acquisitions, new product launches, and increasing number of collaborations and partnerships are some of the latest
trends that have been observed in the global intracranial stents market. Complications associated with the fixing of
intracranial stents are a challenge for the market. Some of the major companies operating in the global intracranial
stents market include Covidien Ltd, DePuy Synthes Companies, Medtonic, MicroPort Scientific Corporation, OBEX
Medical Limited, and Stryker Corporation. Some of the other companies having significant presence in the global
intracranial stents market include Abbott Laboratories, Admedes Schuessler GmbH, Balt Extrusion S.A., Cardiatis, S.A,
and Penumbra, Inc.
Key geographies evaluated in this report are:
North America
Intracranial Stents Market, 2015 - 2021
Page |